0001181431-12-011053.txt : 20120223
0001181431-12-011053.hdr.sgml : 20120223
20120223122219
ACCESSION NUMBER: 0001181431-12-011053
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120214
FILED AS OF DATE: 20120223
DATE AS OF CHANGE: 20120223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YACHMETZ PHILIP K
CENTRAL INDEX KEY: 0001250318
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15313
FILM NUMBER: 12632799
MAIL ADDRESS:
STREET 1: 501 LAFAYETTE AVE
CITY: WYCKOFF
STATE: NJ
ZIP: 07481
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000722104
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 133033811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
BUSINESS PHONE: 7324189300
MAIL ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
FORMER COMPANY:
FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP
DATE OF NAME CHANGE: 19920703
4
1
rrd335615.xml
X0304
4
2012-02-14
0
0000722104
SAVIENT PHARMACEUTICALS INC
SVNT
0001250318
YACHMETZ PHILIP K
SAVIENT PHARMACEUTICALS, INC.
ONE TOWER CENTER, 14TH FLOOR
EAST BRUNSWICK
NJ
08816
0
1
0
0
SVP, General Counsel
Common Stock, $.01 par value per share
2012-02-14
4
S
0
3540
2.02
D
235484
D
These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 13, 2009
/s/ Irina Ishak for Philip Yachmetz
2012-02-23